(July 8, 2016) - Research at the University of Alabama at Birmingham has revealed that urine samples that have been locked in freezers in the NINDS National Repository hold a brand-new type of biomarker—a phosphorylated protein that correlates with the presence and severity of Parkinson's disease. The researchers are digging deeper into these bio-banked samples, to validate the biomarker as a possible guide for future clinical treatments and a monitor of the efficacy of potential new Parkinson's drugs in real time during treatment. Read more…

Click for a printer friendly version

Back to top